Log in to save to my catalogue

CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-hu...

CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-hu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2377702158

CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis

About this item

Full title

CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis

Publisher

United States: Public Library of Science

Journal title

PLoS neglected tropical diseases, 2020-02, Vol.14 (2), p.e0008050-e0008050

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Cutaneous leishmaniasis (CL) affects the lives of 0.7-1 million people every year causing lesions that take months to heal. These lesions can result in disfiguring scars with psychological, social and economic consequences. Antimonials are the first line of therapy for CL, however the treatment is lengthy and linked to significant toxicities; furth...

Alternative Titles

Full title

CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2377702158

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2377702158

Other Identifiers

ISSN

1935-2735,1935-2727

E-ISSN

1935-2735

DOI

10.1371/journal.pntd.0008050

How to access this item